Study Evaluating Conjugated Estrogen Cream for Atrophic Vaginitis

Completed · Phase 3

Conditions studied: Atrophic Vaginitis, Atrophy, Vaginitis

In brief

This protocol is designed to study the effect and safety of 2 low-dose regimens of conjugated estrogen cream (PVC) given vaginally in postmenopausal women with atrophic vaginitis.

Key facts

Study ID

NCT00137371

Run by

Wyeth is now a wholly owned subsidiary of Pfizer

People needed

480

Starts

2005-08-01

Expected to finish

2007-09-01

Last updated by the study team

2007-12-10

Who can join

Age: 45 and older, up to 80. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Generally healthy postmenopausal women with symptoms of atrophic vaginitis including vaginal dryness, vaginal itching, vaginal burning, and/or painful intercourse.
• The subject must have a clinical diagnosis of atrophic vaginitis and an intact uterus.

You may not qualify if…

• Women who do not have a clinical diagnosis of atrophic vaginitis.

Where it is running

• Study site — Tucson, Arizona, United States
• Study site — Encinitas, California, United States
• Study site — San Diego, California, United States
• Study site — Torrance, California, United States
• Study site — Aurora, Colorado, United States
• Study site — Brooksville, Florida, United States
• Study site — Miami, Florida, United States
• Study site — St. Petersburg, Florida, United States
• Study site — Tampa, Florida, United States
• Study site — West Palm Beach, Florida, United States
• Study site — Atlanta, Georgia, United States
• Study site — Augusta, Georgia, United States
• Study site — Chicago, Illinois, United States
• Study site — Metairie, Louisiana, United States
• Study site — Troy, Michigan, United States
• Study site — St Louis, Missouri, United States
• Study site — Omaha, Nebraska, United States
• Study site — New Brunswick, New Jersey, United States
• Study site — Chapel Hill, North Carolina, United States
• Study site — Winston-Salem, North Carolina, United States
• Study site — Oklahoma City, Oklahoma, United States
• Study site — Danville, Pennsylvania, United States
• Study site — Philadelphia, Pennsylvania, United States
• Study site — Pittsburgh, Pennsylvania, United States
• Study site — Carrollton, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.